CST3 and chronic kidney disease: In addition to being a promising biomarker of early-stage CKD, serum cystatin C has been identified as a predictor of CKD-related complications(17) and an independent risk factor for CVD(15,19–21) and all-cause and cardiovascular mortality among older adults without renal impairment or with CKD(22,23).